Iterum Therapeutics (NASDAQ:ITRM) Upgraded by Zacks Investment Research to Hold

Iterum Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Iterum Therapeutics Upgraded by Zacks Investment Research on 10/19/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More Iterum Therapeutics (NASDAQ:ITRM) Upgraded by Zacks Investment Research to Hold

Earnings and Growth Analysis : Iterum Therapeutics (NASDAQ:ITRM)

Earnings results for Iterum Therapeutics , Analyst Opinion on Iterum Therapeutics , Earnings and Valuation of (NASDAQ:ITRM), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Earnings and Growth Analysis : Iterum Therapeutics (NASDAQ:ITRM)

Earnings Report: Here’s what to expect from Iterum Therapeutics (NASDAQ:ITRM)

Earnings results for Iterum Therapeutics , Analyst Opinion on Iterum Therapeutics , Earnings and Valuation of (NASDAQ:ITRM), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Earnings Report: Here’s what to expect from Iterum Therapeutics (NASDAQ:ITRM)

thoughts on these estimates, before EPS results? NASDAQ:HARP, NASDAQ:DOMO, NASDAQ:TIPT, NASDAQ:ITRM

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…

View More thoughts on these estimates, before EPS results? NASDAQ:HARP, NASDAQ:DOMO, NASDAQ:TIPT, NASDAQ:ITRM

Analysts Estimate Report : What to Look Out for Iterum Therapeutics (NASDAQ:ITRM)

Earnings results for Iterum Therapeutics , Analyst Opinion on Iterum Therapeutics , Earnings and Valuation of (NASDAQ:ITRM), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Analysts Estimate Report : What to Look Out for Iterum Therapeutics (NASDAQ:ITRM)

Should you short it before the Earnings result? : Iterum Therapeutics (NASDAQ:ITRM)

Earnings results for Iterum Therapeutics , Analyst Opinion on Iterum Therapeutics , Earnings and Valuation of (NASDAQ:ITRM), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Should you short it before the Earnings result? : Iterum Therapeutics (NASDAQ:ITRM)